Registro:

Referencias:

• Abid, F., Tardy, V., Gaouzi, A., Hessni, A.E., Morel, Y., Chabraoui, L., CYP21A2 gene mutation analysis in Moroccan patients with classic form of 21-hydroxylase deficiency: High regional prevalence of p.Q318X mutation and identification of a novel p.L353R mutation (2008) Clinical Chemistry and Laboratory Medicine, 46, pp. 1707-1713
• Amor, M., Parker, K.L., Globerman, H., New, M.I., White, P.C., Mutation in the CYP21B gene (Ile-172—Asn) causes steroid 21-hydroxylase deficiency (1988) Proceedings of the National Academy of Sciences of the United States of America, 85, pp. 1600-1604
• Araújo, R.S., Mendonca, B.B., Barbosa, A.S., Lin, C.J., Marcondes, J.A.M., Billerbeck, A.E.C., Bachega, T.A.S.S., Microconversion between CYP21A2 and CYP21A1P promoter regions causes the nonclassical form of 21-hydroxylase deficiency (2007) Journal of Clinical Endocrinology and Metabolism, 92, pp. 4028-4034
• Balsamo, A., Cacciari, E., Baldazzi, L., Tartaglia, L., Cassio, A., Mantovani, V., Zappulla, F., CYP21 analysis and phenotype /genotype relationship in the screened population of the Italian Emilia-Romagna region (2000) Clinical Endocrinology (Oxford), 53, pp. 117-125
• Baradaran-Heravi, A., Vakili, R., Robins, T., Carlsson, J., Ghaemi, N., A'rabi, A., Abbaszadegan, M.R., Three novel CYP21A2 mutations and their protein modelling in patients with classical 21-hydroxylase deficiency from northeastern Iran (2007) Clinical Endocrinology (Oxford), 67, pp. 335-341
• Barbaro, M., Baldazzi, L., Balsamo, A., Lajic, S., Robins, T., Barp, L., Wedell, A., Functional studies of two novel and two rare mutations in the 21-hydroxylase gene (2006) Journal of Molecular Medicine (Berlin), 84, pp. 521-528
• Barbaro, M., Lajic, S., Baldazzi, L., Balsamo, A., Pirazzoli, P., Cicognani, A., Cacciari, E., Functional analysis of two recurrent amino acid substitutions in the CYP21 gene from Italian patients with congenital adrenal hyperplasia (2004) Journal of Clinical Endocrinology and Metabolism, 89, pp. 2402-2407
• Barbaro, M., Soardi, F.C., Mello, M.P., de Wedell, A., Lajic, S., Functional studies of CYP21A2 mutants complement structural and clinical predictions of disease severity in CAH (2012) Clinical Endocrinology (Oxford), 76, pp. 766-768
• Barbaro, M., Soardi, F.C., Östberg, L.J., Persson, B., Mello, M.P., de Wedell, A., Lajic, S., In vitro functional studies of rare CYP21A2 mutations and establishment of an activity gradient for nonclassic mutations improve phenotype predictions in congenital adrenal hyperplasia (2015) Clinical Endocrinology (Oxford), 82, pp. 37-44
• Barbat, B., Bogyo, A., Raux-Demay, M.C., Kuttenn, F., Boué, J., Simon-Bouy, B., Mornet, E., Screening of CYP21 gene mutations in 129 French patients affected by steroid 21-hydroxylase deficiency (1995) Human Mutation, 5, pp. 126-130
• Baumgartner-Parzer, S.M., Schulze, E., Waldhäusl, W., Pauschenwein, S., Rondot, S., Nowotny, P., Vierhapper, H., Mutational spectrum of the steroid 21-hydroxylase gene in Austria: Identification of a novel missense mutation (2001) Journal of Clinical Endocrinology and Metabolism, 86, pp. 4771-4775
• Beck, T., Hastings, R.K., Gollapudi, S., Free, R.C., Brookes, A.J., GWAS Central: A comprehensive resource for the comparison and interrogation of genome-wide association studies (2014) European Journal of Human Genetics, 22, pp. 949-952
• Bernal González, C., Fernández Salas, C., Martínez, S., Ezquieta Zubicaray, B., Premature androgenetic alopecia in adult male with nonclassic 21-OH deficiency. A novel nonsense CYP21A2 mutation (Y336X) in 2 affected siblings (2006) Medicina Clinica (Barcelona), 127, pp. 617-621
• Bidet, M., Bellanné-Chantelot, C., Galand-Portier, M.-B., Tardy, V., Billaud, L., Laborde, K., Kutten, F., Clinical and molecular characterization of a cohort of 161 unrelated women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency and 330 family members (2009) Journal of Clinical Endocrinology and Metabolism, 94, pp. 1570-1578
• Billerbeck, A.E., Bachega, T.A., Frazatto, E.T., Nishi, M.Y., Goldberg, A.C., Marin, M.L., Mendonca, B.B., A novel missense mutation, GLY424SER, in Brazilian patients with 21-hydroxylase deficiency (1999) Journal of Clinical Endocrinology and Metabolism, 84, pp. 2870-2872
• Billerbeck, A.E.C., Mendonca, B.B., Pinto, E.M., Madureira, G., Arnhold, I.J.P., Bachega, T.A.S.S., Three novel mutations in CYP21 gene in Brazilian patients with the classical form of 21-hydroxylase deficiency due to a founder effect (2002) Journal of Clinical Endocrinology and Metabolism, 87, pp. 4314-4317
• Blanchong, C.A., Zhou, B., Rupert, K.L., Chung, E.K., Jones, K.N., Sotos, J.F., Yung Yu, C., Deficiencies of human complement component C4A and C4B and heterozygosity in length variants of RP-C4-CYP21-TNX (RCCX) modules in Caucasians. The load of RCCX genetic diversity on major histocompatibility complex-associated disease (2000) Journal of Experimental Medicine, 191, pp. 2183-2196
• Bleicken, C., Loidi, L., Dhir, V., Parajes, S., Quinteiro, C., Dominguez, F., Krone, N., Functional characterization of three CYP21A2 sequence variants (p.A265V, p.W302S, p.D322G) employing a yeast co-expression system (2009) Human Mutation, 30, pp. E443-E450
• Bojunga, J., Welsch, C., Antes, I., Albrecht, M., Lengauer, T., Zeuzem, S., Structural and functional analysis of a novel mutation of CYP21B in a heterozygote carrier of 21-hydroxylase deficiency (2005) Human Genetics, 117, pp. 558-564
• Bristow, J., Gitelman, S.E., Tee, M.K., Staels, B., Miller, W.L., Abundant adrenal-specific transcription of the human P450c21A “pseudogene (1993) Journal of Biological Chemistry, 268, pp. 12919-12924
• Brønstad, I., Breivik, L., Methlie, P., Wolff, A.S.B., Bratland, E., Nermoen, I., Husebye, E.S., Functional studies of novel CYP21A2 mutations detected in Norwegian patients with congenital adrenal hyperplasia (2014) Endocrine Connections, 3, pp. 67-74
• Bruque, C.D., Delea, M., Fernández, C.S., Orza, V., Taboas, M., Buzzalino, N., Dain, L., Structure-based activity prediction of CYP21A2 stability variants: A survey of available gene variations (2016) Science Reports, 6, p. 39082
• Capoluongo, E., Concolino, P., Minucci, A., Giardina, B., Gene symbol: CYP21A2. disease: Adrenal hyperplasia (2008) Human Genetics, 123, p. 550
• Capoluongo, E., Concolino, P., Vendittelli, F., Zuppi, C., Gene symbol: CYP21A2. Disease: Non-classic 21-Hydroxylase deficiency (2008) Human Genetics, 123, p. 553
• Cargill, M., Altshuler, D., Ireland, J., Sklar, P., Ardlie, K., Patil, N., Lander, E.S., Characterization of single-nucleotide polymorphisms in coding regions of human genes (1999) Nature Genetics, 22, pp. 231-238
• Carvalho, B., Marques, C.J., Pignatelli, D., Barceló, J., Almeida, A.C., Fernandes, S., Carvalho, F., Mutational characterization of steroid 21-hydroxylase gene in Portuguese patients with congenital adrenal hyperplasia (2009) Experimental and Clinical Endocrinology and Diabetes, 118, pp. 505-512
• Carvalho, B., Pereira, M., Marques, C.J., Carvalho, D., Leão, M., Oliveira, J.P., Carvalho, F., Comprehensive genetic analysis and structural characterization of CYP21A2 mutations in CAH patients (2012) Experimental and Clinical Endocrinology and Diabetes, 120, pp. 535-539
• Carvalho, D.F., Miranda, M.C., Gomes, L.G., Madureira, G., Marcondes, J.A.M., Billerbeck, A.E.C., Bachega, T.A., Molecular CYP21A2 diagnosis in 480 Brazilian patients with congenital adrenal hyperplasia before newborn screening introduction (2016) European Journal of Endocrinology, 175, pp. 107-116
• Chang, S.F., Chung, B.C., D ifference in transcriptional activity of two homologous CYP21A genes (1995) Mol Endocrinol, 9, pp. 1330-1336
• Chin, K.K., Chang, S.F., The -104G nucleotide of the human CYP21 gene is important for CYP21 transcription activity and protein interaction (1998) Nucleic Acids Research, 26, pp. 1959-1964
• Chiou, S.H., Hu, M.C., Chung, B.C., A missense mutation at Ile172—Asn or Arg356—Trp causes steroid 21-hydroxylase deficiency (1990) Journal of Biological Chemistry, 265, pp. 3549-3552
• Chu, X., Ding, H., Cui, G., Xu, Y., Wang, D.W., He, Y., Functional consequences of a novel point mutation in the CYP21A2 gene identified in a Chinese Han patient with nonclassic 21-hydroxylase deficiency (2014) Clinical Endocrinology (Oxford), 80, pp. 927-928
• Cock, P.J.A., Antao, T., Chang, J.T., Chapman, B.A., Cox, C.J., Dalke, A., de Hoon, M.J.L., Biopython: Freely available Python tools for computational molecular biology and bioinformatics (2009) Bioinformatics, 25, pp. 1422-1423
• Concolino, P., Mello, E., Patrosso, M.C., Penco, S., Zuppi, C., Capoluongo, E., p.H282N and p.Y191H: 2 novel CYP21A2 mutations in Italian congenital adrenal hyperplasia patients (2012) Metabolism, 61, pp. 519-524
• Concolino, P., Mello, E., Zuppi, C., Capoluongo, E., Molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency: An update of new CYP21A2 mutations (2010) Clinical Chemistry and Laboratory Medicine, 48, pp. 1057-1062
• Concolino, P., Minucci, A., Mello, E., Zuppi, C., Capoluongo, E., A new CYP21A2 nonsense mutation causing severe 21-hydroxylase deficiency (2009) Clinical Chemistry and Laboratory Medicine, 47, pp. 824-825
• Concolino, P., Rizza, R., Costella, A., Carrozza, C., Zuppi, C., Capoluongo, E., CYP21A2 intronic variants causing 21-hydroxylase deficiency (2017) Metabolism, 71, pp. 46-51
• Concolino, P., Santonocito, C., Minucci, A., Carrozza, C., Zuppi, C., Capoluongo, E., Giardina, B., Novel human pathological mutations. Gene Symbol: CYP21A2. Disease: Non-classic 21-hydroxylase deficiency (2007) Human Genetics, 122, p. 559
• Concolino, P., Vendittelli, F., Mello, E., Carelli Alinovi, C., Minucci, A., Carrozza, C., Capoluongo, E., Two novel CYP21A2 missense mutations in Italian patients with 21-hydroxylase deficiency: Identification and functional characterisation (2009) IUBMB Life, 61, pp. 229-235
• Concolino, P., Vendittelli, F., Mello, E., Minucci, A., Carrozza, C., Rossodivita, A., Capoluongo, E., Functional analysis of two rare CYP21A2 mutations detected in Italian patients with a mildest form of congenital adrenal hyperplasia (2009) Clinical Endocrinology (Oxford), 71, pp. 470-476
• Dain, L., Minutolo, C., Buzzalino, N., Belli, S., Oneto, A., Charreau, E., Alba, L., Gene symbol: CYP21A2. Disease: Adrenal hyperplasia, CYP21 (2006) Human Genetics, 119, p. 363
• Dain, L.B., Buzzalino, N.D., Oneto, A., Belli, S., Stivel, M., Pasqualini, T., Alba, L.G., Classical and nonclassical 21-hydroxylase deficiency: A molecular study of Argentine patients (2002) Clinical Endocrinology (Oxford), 56, pp. 239-245
• de Carvalho, D.F., Miranda, M.C., Gomes, L.G., Madureira, G., Marcondes, J.A.M., Billerbeck, A.E.C., Bachega, T.A.S.S., Molecular CYP21A2 diagnosis in 480 Brazilian patients with congenital adrenal hyperplasia before newborn screening introduction (2016) European Journal of Endocrinology, 175, pp. 107-116
• De Paula Michelatto, D., Karlsson, L., Lusa, A.L.G., Silva, C.D.M., Östberg, L.J., Persson, B., Lajic, S., Functional and structural consequences of nine CYP21A2 mutations ranging from very mild to severe effects (2016) International Journal of Endocrinology, 2016, p. 4209670
• den Dunnen, J.T., Dalgleish, R., Maglott, D.R., Hart, R.K., Greenblatt, M.S., McGowan-Jordan, J., Taschner, P.E.M., HGVS recommendations for the description of sequence variants: 2016 Update (2016) Human Mutation, 37, pp. 564-569
• Deneux, C., Tardy, V., Dib, A., Mornet, E., Billaud, L., Charron, D., Kuttenn, F., Phenotype-genotype correlation in 56 women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency (2001) Journal of Clinical Endocrinology and Metabolism, 86, pp. 207-213
• Di Pasquale, G., Wasniewska, M., Caruso, M., Salzano, G., Coco, M., Lombardo, F., De Luca, F., Salt wasting phenotype in a compound heterozygous girl with P482S mutation associated with anovel mutation of CYP21 gene (Q481P) (2005) Journal of Endocrinological Investigation, 28, pp. 1038-1039
• Di Pasquale, L., Indovina, S., Wasniewska, M., Mirabelli, S., Porcelli, P., Rulli, I., De Luca, F., Novel nonsense mutation (W22X) in CYP21A2 gene causing salt-wasting congenital adrenal hyperplasia in a compound heterozygous girl (2007) Journal of Endocrinological Investigation, 30, pp. 806-807
• Dolzan, V., Sólyom, J., Fekete, G., Kovács, J., Rakosnikova, V., Votava, F., Battelino, T., Mutational spectrum of steroid 21-hydroxylase and the genotype-phenotype association in Middle European patients with congenital adrenal hyperplasia (2005) European Journal of Endocrinology, 153, pp. 99-106
• Dolzan, V., Stopar-Obreza, M., Zerjav-Tansek, M., Breskvar, K., Krzisnik, C., Battelino, T., Mutational spectrum of congenital adrenal hyperplasia in Slovenian patients: A novel Ala15Thr mutation and Pro30Leu within a larger gene conversion associated with a severe form of the disease (2003) European Journal of Endocrinology, 149, pp. 137-144
• Donohoue, P.A., van Dop, C., McLean, R.H., White, P.C., Jospe, N., Migeon, C.J., Gene conversion in salt-losing congenital adrenal hyperplasia with absent complement C4B protein (1986) Journal of Clinical Endocrinology and Metabolism, 62, pp. 995-1002
• Dubey, S., Idicula-Thomas, S., Anwaruddin, M., Saravanan, C., Varma, R.R., Maitra, A., A novel 9-bp insertion detected in steroid 21-hydroxylase gene (CYP21A2): Prediction of its structural and functional implications by computational methods (2009) Journal of Biomedical Science, 16, p. 3
• Ezquieta, B., Cueva, E., Varela, J., Oliver, A., Fernández, J., Jariego, C., Non-classical 21-hydroxylase deficiency in children: Association of adrenocorticotropic hormone-stimulated 17-hydroxyprogesterone with the risk of compound heterozygosity with severe mutations (2002) Acta Paediatrica, 91, pp. 892-898
• Ezquieta, B., Oyarzábal, M., Jariego, C.M., Varela, J.M., Chueca, M., A novel frameshift mutation in the first exon of the 21-OH gene found in homozygosity in an apparently nonconsanguineous family (1999) Hormone Research, 51, pp. 135-141
• Fernández, C.S., Bruque, C.D., Taboas, M., Buzzalino, N.D., Espeche, L.D., Pasqualini, T., Dain, L., Misregulation effect of a novel allelic variant in the Z promoter region found in cis with the CYP21A2 p.P482S mutation: Implications for 21-hydroxylase deficiency (2015) Endocrine, 50, pp. 72-78
• Finkielstain, G.P., Chen, W., Mehta, S.P., Fujimura, F.K., Hanna, R.M., Van Ryzin, C., Merke, D.P., Comprehensive genetic analysis of 182 unrelated families with congenital adrenal hyperplasia due to 21-hydroxylase deficiency (2011) Journal of Clinical Endocrinology and Metabolism, 96, pp. E161-E172
• Friães, A., Rêgo, A.T., Aragüés, J.M., Moura, L.F., Mirante, A., Mascarenhas, M.R., Gonçalves, J., CYP21A2 mutations in Portuguese patients with congenital adrenal hyperplasia: Identification of two novel mutations and characterization of four different partial gene conversions (2006) Molecular Genetics and Metabolism, 88, pp. 58-65
• Girgis, R., Ajamian, F., Metcalfe, P., A previously undescribed mutation detected by sequence analysis of CYP21A2 gene in an infant with salt wasting congenital adrenal hyperplasia (2013) Journal of Pediatric Endocrinology and Metabolism, 26, pp. 765-766
• Globerman, H., Amor, M., Parker, K.L., New, M.I., White, P.C., Nonsense mutation causing steroid 21-hydroxylase deficiency (1988) Journal of Clinical Investigation, 82, pp. 139-144
• Gomes, L.G., Huang, N., Agrawal, V., Mendonça, B.B., Bachega, T.A.S.S., Miller, W.L., Extraadrenal 21-hydroxylation by CYP2C19 and CYP3A4: Effect on 21-hydroxylase deficiency (2009) Journal of Clinical Endocrinology and Metabolism, 94, pp. 89-95
• Grischuk, Y., Rubtsov, P., Riepe, F.G., Grötzinger, J., Beljelarskaia, S., Prassolov, V., Krone, N., Four novel missense mutations in the CYP21A2 gene detected in Russian patients suffering from the classical form of congenital adrenal hyperplasia: Identification, functional characterization, and structural analysis (2006) Journal of Clinical Endocrinology and Metabolism, 91, pp. 4976-4980
• Gunn, S.K., Sherman, L.D., Therrell, B.L., Molecular genetics of 21-hydroxylase deficient late-onset adrenal hyperplasia (1993) Seminars in Reproductive Endocrinology, 11, pp. 347-352
• Haider, S., Islam, B., D'Atri, V., Sgobba, M., Poojari, C., Sun, L., New, M.I., Structure-phenotype correlations of human CYP21A2 mutations in congenital adrenal hyperplasia (2013) Proceedings of the National Academy of Science of the United States of America, 110, pp. 2605-2610
• Helmberg, A., Tusie-Luna, M.T., Tabarelli, M., Kofler, R., White, P.C., R339H and P453S: CYP21 mutations associated with nonclassic steroid 21-hydroxylase deficiency that are not apparent gene conversions (1992) Molecular Endocrinology, 6, pp. 1318-1322
• Higashi, Y., Hiromasa, T., Tanae, A., Miki, T., Nakura, J., Kondo, T., Fujii-Kuriyama, Y., Effects of individual mutations in the P-450(C21) pseudogene on the P-450(C21) activity and their distribution in the patient genomes of congenital steroid 21-hydroxylase deficiency (1991) Journal of Biochemistry, 109, pp. 638-644
• Higashi, Y., Tanae, A., Inoue, H., Fujii-Kuriyama, Y., Evidence for frequent gene conversion in the steroid 21-hydroxylase P-450(C21) gene: Implications for steroid 21-hydroxylase deficiency (1988) American Journal of Human Genetics, 42, pp. 17-25
• Higashi, Y., Yoshioka, H., Yamane, M., Gotoh, O., Fujii-Kuriyama, Y., Complete nucleotide sequence of two steroid 21-hydroxylase genes tandemly arranged in human chromosome: A pseudogene and a genuine gene (1986) Proceedings of the National Academy of Science of the United States of America, 83, pp. 2841-2845
• Hsu, N.C., Guzov, V.M., Hsu, L.C., Chung, B.C., Characterization of the consequence of a novel Glu-380 to Asp mutation by expression of functional P450c21 in Escherichia coli (1999) Biochimica et Biophysica Acta, 1430, pp. 95-102
• Janner, M., Pandey, A.V., Mullis, P.E., Flück, C.E., Clinical and biochemical description of a novel CYP21A2 gene mutation 962_963insA using a new 3D model for the P450c21 protein (2006) European Journal of Endocrinology, 155, pp. 143-151
• Jiang, L., Song, L.L., Wang, H., Wang, J.L., Wang, P.P., Zhou, H.B., Zhang, X.L., Identification and functional characterization of a novel mutation P459H and a rare mutation R483W in the CYP21A2 gene in two Chinese patients with simple virilizing form of congenital adrenal hyperplasia (2012) Journal of Endocrinological Investigation, 35, pp. 485-489
• Katsumata, N., Shinagawa, T., Horikawa, R., Fujikura, K., Novel intronic CYP21A2 mutation in a Japanese patient with classic salt-wasting steroid 21-hydroxylase deficiency (2010) Metabolism, 59, pp. 1628-1632
• Kaupert, L., Lemos-Marini, S., De Mello, M., Moreira, R., Brito, V., Jorge, A., Bachega, T., The effect of fetal androgen metabolism-related gene variants on external genitalia virilization in congenital adrenal hyperplasia (2013) Clinical Genetics, 84, pp. 482-488
• Khajuria, R., Walia, R., Bhansali, A., Prasad, R., The spectrum of CYP21A2 mutations in congenital adrenal hyperplasia in an Indian cohort (2017) Clinica Chimica Acta, 464, pp. 189-194
• Kharrat, M., Tardy, V., M'Rad, R., Maazoul, F., Ben Jemaa, L., Refaï, M., Chaabouni, H., Molecular genetic analysis of Tunisian patients with a classic form of 21-hydroxylase deficiency: Identification of four novel mutations and high prevalence of Q318X mutation (2004) Journal of Clinical Endocrinology and Metabolism, 89, pp. 368-374
• Kharrat, M., Tardy, V., M'rad, R., Maazoul, F., Morel, Y., Chaabouni, H., A novel 13-bp deletion in exon 1 of CYP21 gene causing severe congenital adrenal hyperplasia (2005) Diagnostic Molecular Pathology, 14, pp. 250-252
• Kirac, D., Guney, A.I., Akcay, T., Guran, T., Ulucan, K., Turan, S., Bereket, A., The frequency and the effects of 21-hydroxylase gene defects in congenital adrenal hyperplasia patients (2014) Annals of Human Genetics, 78, pp. 399-409
• Kirby-Keyser, L., Porter, C.C., Donohoue, P.A., E380D: A novel point mutation of CYP21 in an HLA-homozygous patient with salt-losing congenital adrenal hyperplasia due to 21-hydroxylase deficiency (1997) Human Mutation, 9, pp. 181-182
• Koppens, P.F., Hoogenboezem, T., Halley, D.J., Barendse, C.A., Oostenbrink, A.J., Degenhart, H.J., Family studies of the steroid 21-hydroxylase and complement C4 genes define 11 haplotypes in classical congenital adrenal hyperplasia in The Netherlands (1992) European Journal Pediatrics, 151, pp. 885-892
• Koyama, S., Toyoura, T., Saisho, S., Shimozawa, K., Yata, J., Genetic analysis of Japanese patients with 21-hydroxylase deficiency: Identification of a patient with a new mutation of a homozygous deletion of adenine at codon 246 and patients without demonstrable mutations within the structural gene for CYP21 (2002) Journal of Clinical Endocrinology and Metabolism, 87, pp. 2668-2673
• Krone, N., Braun, A., Roscher, A.A., Knorr, D., Schwarz, H.P., Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive genotyping in 155 unrelated, well defined patients from southern Germany (2000) Journal of Clinical Endocrinology and Metabolism, 85, pp. 1059-1065
• Krone, N., Braun, A., Roscher, A.A., Schwarz, H.P., A novel frameshift mutation (141delT) in exon 1 of the 21-hydroxylase gene (CYP21) in a patient with the salt wasting form of congenital adrenal hyperplasia. Mutation in brief no. 255. Online (1999) Human Mutation, 14, pp. 90-91
• Krone, N., Riepe, F.G., Partsch, C.-J., Vorhoff, W., Brämswig, J., Sippell, W.G., Three novel point mutations of the CYP21 gene detected in classical forms of congenital adrenal hyperplasia due to 21-hydroxylase deficiency (2006) Experimental and Clinical Endocrinology and Diabetes, 114, pp. 111-117
• Krone, N., Roscher, A.A., Schwarz, H.P., Braun, A., Comprehensive analytical strategy for mutation screening in 21-hydroxylase deficiency (1998) Clinical Chemistry, 44, pp. 2075-2082
• Krone, N., Riepe, F.G., Grötzinger, J., Partsch, C.-J., Brämswig, J., Sippell, W.G., The residue E351 is essential for the activity of human 21-hydroxylase: Evidence from a naturally occurring novel point mutation compared with artificial mutants generated by single amino acid substitutions (2005) Journal of Molecular Medicine (Berlin), 83, pp. 561-568
• Krone, N., Riepe, F.G., Grötzinger, J., Partsch, C.-J., Sippell, W.G., Functional characterization of two novel point mutations in the CYP21 gene causing simple virilizing forms of congenital adrenal hyperplasia due to 21-hydroxylase deficiency (2005) Journal of Clinical Endocrinology and Metabolism, 90, pp. 445-454
• Krone, N., Rose, I.T., Willis, D.S., Hodson, J., Wild, S.H., Doherty, E.J., Arlt, W., Genotype-phenotype correlation in 153 adult patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency: Analysis of the United Kingdom Congenital adrenal Hyperplasia Adult Study Executive (CaHASE) cohort (2013) Journal of Clinical Endocrinology and Metabolism, 98
• Lachance, J., Vernot, B., Elbers, C.C., Ferwerda, B., Froment, A., Bodo, J.-M., Tishkoff, S.A., Evolutionary history and adaptation from high-coverage whole-genome sequences of diverse African hunter-gatherers (2012) Cell, 150, pp. 457-469
• Lajic, S., Levo, A., Nikoshkov, A., Lundberg, Y., Partanen, J., Wedell, A., A cluster of missense mutations at Arg356 of human steroid 21-hydroxylase may impair redox partner interaction (1997) Human Genetics, 99, pp. 704-709
• Lajic, S., Nikoshkov, A., Holst, M., Wedell, A., Effects of missense mutations and deletions on membrane anchoring and enzyme function of human steroid 21-hydroxylase (P450c21) (1999) Biochemical and Biophysical Research Communications, 257, pp. 384-390
• Lajić, S., Robins, T., Krone, N., Schwarz, H.P., Wedell, A., CYP21 mutations in simple virilizing congenital adrenal hyperplasia (2001) Journal of Molecular Medicine (Berlin), 79, pp. 581-586
• Lajic, S., Wedell, A., An intron 1 splice mutation and a nonsense mutation (W23X) in CYP21 causing severe congenital adrenal hyperplasia (1996) Human Genetics, 98, pp. 182-184
• Lajić, S., Clauin, S., Robins, T., Vexiau, P., Blanché, H., Bellanne-Chantelot, C., Wedell, A., Novel mutations in CYP21 detected in individuals with hyperandrogenism (2002) Journal of Clinical Endocrinology and Metabolism, 87, pp. 2824-2829
• Lau, I.F., Soardi, F.C., Lemos-Marini, S.H., Guerra, G., Jr., Baptista, M.T., De Mello, M.P., H28+C insertion in the CYP21 gene: A novel frameshift mutation in a Brazilian patient with the classical form of 21-hydroxylase deficiency (2001) Journal of Clinical Endocrinology and Metabolism, 86, pp. 5877-5880
• Lee, H.H., Chang, S.F., Multiple transcripts of the CYP21 gene are generated by the mutation of the splicing donor site in intron 2 from GT to AT in 21-hydroxylase deficiency (2001) Journal of Endocrinology, 171, pp. 397-402
• Lee, H.H., Chao, H.T., Lee, Y.J., Shu, S.G., Chao, M.C., Kuo, J.M., Chung, B.C., Identification of four novel mutations in the CYP21 gene in congenital adrenal hyperplasia in the Chinese (1998) Human Genetics, 103, pp. 304-310
• Lek, M., Karczewski, K.J., Minikel, V., Samocha, K.E., Banks, E., Fennell, T., MacArthur, D.G., Analysis of protein-coding genetic variation in 60,706 humans (2016) Nature, 536, pp. 285-291
• Levo, A., Partanen, J., Novel mutations in the human CYP21 gene (2001) Prenatal Diagnosis, 21, pp. 885-889
• Levo, A., Partanen, J., Novel nonsense mutation (W302X) in the steroid 21-hydroxylase gene of a Finnish patient with the salt-wasting form of congenital adrenal hyperplasia (1997) Human Mutation, 9, pp. 363-365
• Lobato, M.N., Ordóñez-Sánchez, M.L., Tusié-Luna, M.T., Meseguer, A., Mutation analysis in patients with congenital adrenal hyperplasia in the Spanish population: Identification of putative novel steroid 21-hydroxylase deficiency alleles associated with the classic form of the disease (1999) Human Heredity, 49, pp. 169-175
• Loidi, L., Quinteiro, C., Parajes, S., Barreiro, J., Lestón, D.G., Cabezas-Agrícola, J.M., Domínguez, F., High variability in CYP21A2 mutated alleles in Spanish 21-hydroxylase deficiency patients, six novel mutations and a founder effect (2006) Clinical Endocrinology (Oxford), 64, pp. 330-336
• Loke, K.Y., Lee, Y.S., Lee, W.W., Poh, L.K., Molecular analysis of CYP-21 mutations for congenital adrenal hyperplasia in Singapore (2001) Hormone Research, 55, pp. 179-184
• Marino, R., Ramirez, P., Galeano, J., Perez Garrido, N., Rocco, C., Ciaccio, M., Belgorosky, A., Steroid 21-hydroxylase gene mutational spectrum in 454 Argentinean patients: Genotype-phenotype correlation in a large cohort of patients with congenital adrenal hyperplasia (2011) Clinical Endocrinology (Oxford), 75, pp. 427-435
• Massimi, A., Malaponti, M., Federici, L., Vinciguerra, D., Manca Bitti, M.L., Vottero, A., Porzio, O., Functional and structural analysis of four novel mutations of CYP21A2 gene in Italian patients with 21-hydroxylase deficiency (2014) Hormone and Metabolic Research, 46, pp. 515-520
• Menabò, S., Balsamo, A., Baldazzi, L., Barbaro, M., Nicoletti, A., Conti, V., Cicognani, A., A sequence variation in 3’UTR of CYP21A2 gene correlates with a mild form of congenital adrenal hyperplasia (2012) Journal of Endocrinology Investigation, 35, pp. 298-305
• Menassa, R., Tardy, V., Despert, F., Bouvattier-Morel, C., Brossier, J.P., Cartigny, M., Morel, Y., p.H62L, a rare mutation of the CYP21 gene identified in two forms of 21-hydroxylase deficiency (2008) Journal of Clinical Endocrinology and Metabolism, 93, pp. 1901-1908
• Milacic, I., Barac, M., Milenkovic, T., Ugrin, M., Klaassen, K., Skakic, A., Stojiljkovic, M., Molecular genetic study of congenital adrenal hyperplasia in Serbia: Novel p.Leu129Pro and p.Ser165Pro CYP21A2 gene mutations (2015) Journal of Endocrinology Investigation, 38, pp. 1199-1210
• Miller, W.L., Clinical review 54: Genetics, diagnosis, and management of 21-hydroxylase deficiency (1994) Journal of Clinical Endocrinology and Metabolism, 78, pp. 241-246
• Minutolo, C., Nadra, A.D., Fernández, C., Taboas, M., Buzzalino, N., Casali, B., Dain, L., Structure-based analysis of five novel disease-causing mutations in 21-hydroxylase-deficient patients (2011) PLoS One, 6
• Mottaz, A., David, F.P.A., Veuthey, A.-L., Yip, Y.L., Easy retrieval of single amino-acid polymorphisms and phenotype information using SwissVar (2010) Bioinformatics, 26, pp. 851-852
• Nerbert, D.W., Nelson, D.R., Coon, M.J., Estabrook, R.W., Feyereisen, R., Fujii-Kuriyama, Y., Waxman, D.J., The P450 superfamily: Update on new sequences, gene mapping, and recommended nomenclature (1991) DNA and Cell Biology, 10, pp. 1-14
• New, M.I., Abraham, M., Gonzalez, B., Dumic, M., Razzaghy-Azar, M., Chitayat, D., Yuen, T., Genotype-phenotype correlation in 1,507 families with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency (2013) Proceedings of the National Academy of Sciences of the United States America, 110, pp. 2611-2616
• New, M.I., White, P.C., Pang, S., Dupont, B., Speiser, P., (1989) The Metabolic Basis of Inherited Disease, pp. 1881-1917. , 6th ed, New York, McGraw Hill
• Nikoshkov, A., Lajic, S., Holst, M., Wedell, A., Luthman, H., Synergistic effect of partially inactivating mutations in steroid 21-hydroxylase deficiency (1997) Journal of Clinical Endocrinology and Metabolism, 82, pp. 194-199
• Nikoshkov, A., Lajic, S., Vlamis-Gardikas, A., Tranebjaerg, L., Holst, M., Wedell, A., Luthman, H., Naturally occurring mutants of human steroid 21-hydroxylase (P450c21) pinpoint residues important for enzyme activity and stability (1998) Journal of Biological Chemistry, 273, pp. 6163-6165
• Nunez, B.S., Lobato, M.N., White, P.C., Meseguer, A., Functional analysis of four CYP21 mutations from spanish patients with congenital adrenal hyperplasia (1999) Biochemical and Biophysical Research Communications, 262, pp. 635-637
• Ohlsson, G., Müller, J., Skakkebaek, N.E., Schwartz, M., Steroid 21-hydroxylase deficiency: Mutational spectrum in Denmark, three novel mutations, and in vitro expression analysis (1999) Human Mutation, 13, pp. 482-486
• Oliveros, J.C., (2007) Venny. An interactive tool for comparing lists with Venn's diagrams, , https//bioinfogp.cnb.csic.es/tools/venny/index.html, Retrieved from
• Ordoñez-Sánchez, M.L., Ramírez-Jiménez, S., López-Gutierrez, A.U., Riba, L., Gamboa-Cardiel, S., Cerrillo-Hinojosa, M., Tusié-Luna, M.T., Molecular genetic analysis of patients carrying steroid 21-hydroxylase deficiency in the Mexican population: Identification of possible new mutations and high prevalence of apparent germ-line mutations (1998) Human Genetics, 102, pp. 170-177
• Owerbach, D., Sherman, L., Ballard, A.L., Azziz, R., Pro-453 to Ser mutation in CYP21 is associated with nonclassic steroid 21-hydroxylase deficiency (1992) Molecular Endocrinology, 6, pp. 1211-1215
• Pinto, G., Tardy, V., Trivin, C., Thalassinos, C., Lortat-Jacob, S., Nihoul-Fékété, C., Brauner, R., Follow-up of 68 children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency: Relevance of genotype for management (2003) Journal of Clinical Endocrinology and Metabolism, 88, pp. 2624-2633
• Raisingani, M., Contreras, M.F., Prasad, K., Pappas, J.G., Kluge, M.L., Shah, B., David, R., Unusual phenotype of congenital adrenal hyperplasia (CAH) with a novel mutation of the CYP21A2 gene (2016) Journal of Pediatric Endocrinology and Metabolism, 29, pp. 867-871
• Riepe, F.G., Hiort, O., Grötzinger, J., Sippell, W.G., Krone, N., Holterhus, P.-M., Functional and structural consequences of a novel point mutation in the CYP21A2 gene causing congenital adrenal hyperplasia: Potential relevance of helix C for P450 oxidoreductase-21-hydroxylase interaction (2008) Journal of Clinical Endocrinology and Metabolism, 93, pp. 2891-2895
• Robins, T., Barbaro, M., Lajic, S., Wedell, A., Not all amino acid substitutions of the common cluster E6 mutation in CYP21 cause congenital adrenal hyperplasia (2005) Journal of Clinical Endocrinology and Metabolism, 90, pp. 2148-2153
• Robins, T., Bellanne-Chantelot, C., Barbaro, M., Cabrol, S., Wedell, A., Lajic, S., Characterization of novel missense mutations in CYP21 causing congenital adrenal hyperplasia (2007) Journal of Molecular Medicine (Berlin), 85, pp. 247-255
• Robins, T., Carlsson, J., Sunnerhagen, M., Wedell, A., Persson, B., Molecular model of human CYP21 based on mammalian CYP2C5: Structural features correlate with clinical severity of mutations causing congenital adrenal hyperplasia (2006) Molecular Endocrinology, 20, pp. 2946-2964
• Rodrigues, N.R., Dunham, I., Yu, C.Y., Carroll, M.C., Porter, R.R., Campbell, R.D., Molecular characterization of the HLA-linked steroid 21-hydroxylase B gene from an individual with congenital adrenal hyperplasia (1987) EMBO Journal, 6, pp. 1653-1661
• Rubtsov, P.M., Igudin, E.L., Pichugina, M.I., Spirin, V., Prasolov, V.S., Tulpakov, A.N., Characterization of new splicing mutation in steroid 21-hydroxylase gene Bioorganicheskaia Khimiia, 37, pp. 815-820
• Rubtsov, P.M., Igudin, E.L., Pichugina, M.Y., Spirin, V., Prassolov, V.S., Tyulpakov, A.N., Characterization of a new splicing mutation in the steroid 21-hydroxylase gene (2011) Russian Journal of Bioorganic Chemistry, 37, pp. 739-743
• Sherry, S.T., Ward, M.H., Kholodov, M., Baker, J., Phan, L., Smigielski, E.M., Sirotkin, K., dbSNP: The NCBI database of genetic variation (2001) Nucleic Acids Research, 29, pp. 308-311
• Soardi, F.C., Barbaro, M., Lau, I.F., Lemos-Marini, V., Baptista, M.T.M., Guerra-Junior, G., de Mello, M.P., Inhibition of CYP21A2 enzyme activity caused by novel missense mutations identified in Brazilian and Scandinavian patients (2008) Journal of Clinical Endocrinology and Metabolism, 93, pp. 2416-2420
• Speiser, P.W., New, M.I., White, P.C., Molecular genetic analysis of nonclassic steroid 21-hydroxylase deficiency associated with HLA-B14,DR1 (1988) New England Journal of Medicine, 319, pp. 19-23
• Speiser, P.W., White, P.C., Congenital adrenal hyperplasia (2003) New England Journal of Medicine, 349, pp. 776-788
• Stikkelbroeck, N.M.M.L., Hoefsloot, L.H., de, W.I.J., Otten, B.J., Hermus, A.R.M.M., Sistermans, E.A., CYP21 gene mutation analysis in 198 patients with 21-hydroxylase deficiency in The Netherlands: Six novel mutations and a specific cluster of four mutations (2003) Journal of Clinical Endocrinology and Metabolism, 88, pp. 3852-3859
• Taboas, M., Gómez Acuña, L., Scaia, M.F., Bruque, C.D., Buzzalino, N., Stivel, M., Dain, L., Functional studies of p.R132C, p.R149C, p.M283V, p.E431K, and a novel c.652-2A>G mutations of the CYP21A2 gene (2014) PLoS One, 9
• Tardy, V., Menassa, R., Sulmont, V., Lienhardt-Roussie, A., Lecointre, C., Brauner, R., Morel, Y., Phenotype-genotype correlations of 13 rare CYP21A2 mutations detected in 46 patients affected with 21-hydroxylase deficiency and in one carrier (2010) Journal of Clinical Endocrinology and Metabolism, 95, pp. 1288-1300
• Tardy, V., Gene symbol: CYP21A2. Disease: Steroid 21-hydroxylase deficiency (2006) Human Genetics, 119, p. 363
• Tardy, V.T., Gene symbol: CYP21A2 (2007) Human Genetics, 121, pp. 292-293
• Tardy, V.T., Morel, Y., Gene symbol: CYP21A2 (2007) Human Genetics, 121, p. 294
• Tardy, V.T., Morel, Y., Gene symbol: CYP21A2 (2007) Human Genetics, 121, p. 293
• Tardy, V.T., Morel, Y., Gene symbol: CYP21A2 (2007) Human Genetics, 121, pp. 293-294
• Thompson, J.D., Higgins, D.G., Gibson, T.J., CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice (1994) Nucleic Acids Research, 22, pp. 4673-4680
• Toraman, B., Ökten, A., Kalay, E., Karagüzel, G., Dinçer, T., Açıkgöz, E.G., Karagüzel, A., Investigation of CYP21A2 mutations in Turkish patients with 21-hydroxylase deficiency and a novel founder mutation (2013) Gene, 513, pp. 202-208
• Tusie-Luna, M.T., Speiser, P.W., Dumic, M., New, M.I., White, P.C., A mutation (Pro-30 to Leu) in CYP21 represents a potential nonclassic steroid 21-hydroxylase deficiency allele (1991) Molecular Endocrinology, 5, pp. 685-692
• Tusie-Luna, M.T., Traktman, P., White, P.C., Determination of functional effects of mutations in the steroid 21-hydroxylase gene (CYP21) using recombinant vaccinia virus (1990) Journal of Biological Chemistry, 265, pp. 20916-20922
• Usui, T., Nishisho, K., Kaji, M., Ikuno, N., Yorifuji, T., Yasuda, T., Shimatsu, A., Three novel mutations in Japanese patients with 21-hydroxylase deficiency (2004) Hormone Research, 61, pp. 126-132
• Vrzalová, Z., Hrubá, Z., St'ahlová Hrabincová, E., Pouchlá, S., Votava, F., Kolousková, S., Fajkusová, L., Identification of CYP21A2 mutant alleles in Czech patients with 21-hydroxylase deficiency (2010) International Journal of Molecular Medicine, 26, pp. 595-603
• Wang, H., Jiang, L., Wang, P., Zhou, H., Wang, J., Song, L., Mutation analysis in families with 21-hydroxylase deficiency (2007) Zhonghua Yi Xue Yi Chuan Xue Za Zhi, 24, pp. 681-684
• Wang, R., Yu, Y., Ye, J., Han, L., Qiu, W., Zhang, H., Gu, X., 21-Hydroxylase deficiency-induced congenital adrenal hyperplasia in 230 Chinese patients: Genotype–phenotype correlation and identification of nine novel mutations (2016) Steroids, 108, pp. 47-55
• Wasniewska, M., Mirabelli, S., Baldazzi, L., Salzano, G., Messina, M.F., Lombardo, F., De Luca, F., Novel mutation of CYP21A2 gene (N387K) affecting a non-conserved amino acid residue in exon 9 (2009) Journal of Endocrinological Investigation, 32, p. 633
• Wedell, A., Luthman, H., Steroid 21-hydroxylase deficiency: Two additional mutations in salt-wasting disease and rapid screening of disease-causing mutations (1993) Human Molecular Genetics, 2, pp. 499-504
• Wedell, A., Luthman, H., Steroid 21-hydroxylase (P450c21): A new allele and spread of mutations through the pseudogene (1993) Human Genetics, 91, pp. 236-240
• Wedell, A., Ritzén, E.M., Haglund-Stengler, B., Luthman, H., Steroid 21-hydroxylase deficiency: Three additional mutated alleles and establishment of phenotype-genotype relationships of common mutations (1992) Proceedings of the National Academy of Sciences of the United States of America, 89, pp. 7232-7236
• White, P.C., New, M.I., Dupont, B., Structure of human steroid 21-hydroxylase genes (1986) Proceedings of the National Academy of Sciences of the United States of America, 83, pp. 5111-5115
• White, P.C., Speiser, P.W., Congenital adrenal hyperplasia due to 21-hydroxylase deficiency (2000) Endocrine Reviews, 21, pp. 245-291
• Witchel, S.F., Smith, R., Suda-Hartman, M., Identification of CYP21 mutations, one novel, by single strand conformational polymorphism (SSCP) analysis. Mutations in brief no. 218. Online (1999) Human Mutation, 13, p. 172
• Wu, D.A., Chung, B.C., Mutations of P450c21 (steroid 21-hydroxylase) at Cys428, Val281, and Ser268 result in complete, partial, or no loss of enzymatic activity, respectively (1991) Journal of Clinical Investigation, 88, pp. 519-523
• Yu, Y., Wang, J., Huang, X., Wang, Y., Yang, P., Li, J., Fu, Q., Molecular characterization of 25 Chinese pedigrees with 21-hydroxylase deficiency (2011) Genetic Testing and Molecular Biomarkers, 15, pp. 137-142
• Zeng, X., Witchel, S.F., Dobrowolski, S.F., Moulder, V., Jarvik, J.W., Telmer, C.A., Detection and assignment of CYP21 mutations using peptide mass signature genotyping (2004) Molecular Genetics and Metabolism, 82, pp. 38-47

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------